Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Short-term Investments (2010 - 2026)

Geron's (GERN) quarterly Short-term Investments came in at $238.2 million in Q2 2026, down 23.22% year-over-year from $310.2 million in Q2 2025, and down 2.18% quarter-over-quarter from $243.5 million in Q1 2026.

Analysis

Geron (GERN) Short-term Investments (2010 - 2026) Analysis & Trends

Geron has disclosed Short-term Investments across 17 years of filings, most recently posting $238.2 million for Q2 2026.

  • In Q2 2026, Short-term Investments fell 23.22% year-over-year to $238.2 million; the TTM figure through Jun 2026 stood at $238.2 million (down 23.22% YoY), while the FY2025 annual figure was $280.4 million, down 14.41% from the prior year.
  • Short-term Investments came in at $238.2 million for Q2 2026 at Geron, down from $243.5 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $327.6 million in Q4 2024 to a low of $115.9 million in Q4 2022.
  • Average Short-term Investments over 5 years is $247.3 million, with a median of $265.8 million recorded in 2023.
  • Year-over-year, Short-term Investments fell 24.59% in 2022 and jumped 127.5% in 2023.
  • Over 5 years, Short-term Investments stood at $115.9 million in 2022, then jumped by 127.5% to $263.7 million in 2023, then gained by 24.22% to $327.6 million in 2024, then declined by 14.41% to $280.4 million in 2025, then dropped by 15.04% to $238.2 million in 2026.
  • Per Business Quant data, the three most recent Short-term Investments figures were $238.2 million in Q2 2026, $243.5 million in Q1 2026, and $280.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Geron 914.60 Mn 613.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 238.21 Mn
Mar 31, 2026 243.51 Mn
Dec 31, 2025 280.36 Mn
Sep 30, 2025 302.42 Mn
Jun 30, 2025 310.25 Mn
Mar 31, 2025 313.13 Mn
Dec 31, 2024 327.55 Mn
Sep 30, 2024 279.43 Mn
Jun 30, 2024 245.79 Mn
Mar 31, 2024 253.29 Mn
Dec 31, 2023 263.68 Mn
Sep 30, 2023 282.82 Mn
Jun 30, 2023 314.48 Mn
Mar 31, 2023 267.96 Mn
Dec 31, 2022 115.90 Mn
Sep 30, 2022 133.68 Mn
Jun 30, 2022 143.23 Mn
Mar 31, 2022 135.35 Mn
Dec 31, 2021 148.85 Mn
Sep 30, 2021 147.08 Mn